Contact
Helmi Räsänen
Helmi Räsänen, Associate
helmi.rasanen@krogerus.com
+358 (0)40 589 3338
Contact Helmi Räsänen
Abstract 14

Krogerus advises DNB Carnegie on Reaktor's planned initial public offering and listing on the regula...

25 May 2026 — Capital Markets and Public M&A ...
Abstract04

Krogerus advises Bioretec on its rights offering

15 May 2026 — Capital Markets and Public M&A
Abstract 14

Krogerus advises Stifel on Faron's rights offering

15 Apr 2026 — Capital Markets and Public M&A ...